Search Within

Kenneth K Ng

  1. "1999"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Center for Hematologic Malignancies (1)
  5. Hematologic Malignancies, Division of (1)
  6. Lymphoma (1)

More Groups

People
  1. Mark Kris (4)
  2. Vincent Miller (4)
  3. Lee Krug (3)
  4. Robert Heelan (3)
  5. Stefan Grant (3)
  6. Andrew Zelenetz (1)

More People

Years
  1. 1999 (4)
Publications
  1. Cancer (1)
  2. Clinical Cancer Research (1)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (1)
  4. Seminars in Oncology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (1)
  3. Wiley Blackwell (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of docetaxel and vinorelbine in advanced non-small cell lung cancer (NSCLS) with analysis of bcl-2 and bax expression
    Meeting Abstract

    Krug, L. M.; Filippa, D. A.; Kris, M. G.; Zelenetz, A.; Heelan, R. T.; Grant, S. C.; Ng, K. K.; Pizzo, B. A.; Miller, V. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin (PDX), a new antifolate
    Meeting Abstract

    Krug, L. M.; Ng, K. K.; Miller, V. A.; Heelan, R. T.; Tong, W.; Kelly, J.; Sirotnak, F. M.; Kris, M. G.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Strategies to eradicate minimal residual disease in small cell lung cancer: High-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination
    Journal Article

    Krug, L. M.; Grant, S. C.; Miller, V. A.; Ng, K. K.; Kris, M. G.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with Stage III nonsmall cell lung carcinoma
    Journal Article

    Ng, K. K.; Kris, M. G.; Ginsberg, R. J.; Heelan, R. T.; Pisters, K. M. W.; Miller, V. A.; Grant, S. C.; Bains, M.; Rusch, V.; Rosenzweig, K. E.; more...
    Cancer (1999)

    Fulltext@MSK | Save